Each test available at Medivolve’s Collection Sites locations have received an Emergency Use Authorization from the FDA. Results are confirmed and provided by CLIA certified labs.
1 Patients are eligible for $0 upfront cost if you meet the clinical guidelines for COVID-19 testing. 2 The $99 service fee is for the Rapid Antigen test only. PCR and Rapid Antibody tests are billed to insurance or respective government programs. 3 High demand at labs can delay turnaround times.
Collection Sites, LLC is a wholly-owned subsidiary of Medivolve– a publicly traded company that seeks out disruptive technologies, ground-breaking innovations, and exclusive partnerships to help combat COVID-19.
Our team is built to search for challenges, develop solutions, and solve the crisis at hand through strategic investment of human and financial resources.
Medivolve provides $0 out-of-pocket COVID-19 testing to anyone with recent exposure or symptoms. Patients do not need to pay for expedited PCR testing if there has been a recent exposure. Patients simply need to provide their insurance information or truthfully declare they are uninsured (or undocumented), and the third-party laboratory will bill patient insurance or the federally funded program, respectively. Patients will not be billed.